US Oncology Launches Oncology-Specific EHR

Publication
Article
OncologyONCOLOGY Vol 23 No 8
Volume 23
Issue 8

US Oncology, Inc, announced the launch of iKnowMed-an oncology-specific electronic health record (EHR) system designed by oncologists for oncologists-to the open market.

US Oncology, Inc, announced the launch of iKnowMed-an oncology-specific electronic health record (EHR) system designed by oncologists for oncologists-to the open market. Features of iKnowMed include oncology-specific terminology, decision support, outcomes reporting, and imaging reports.

Articles in this issue
Resolving Confusion: The New Realities of Mantle Cell Lymphoma
Something Old, Something New: Options for Treating Relapsed Mantle Cell Lymphoma
Supraclavicular Extraskeletal Myxoid Chondrosarcoma Presenting With a Sensorimotor Polyneuropathy Associated With Anti-Hu Antibodies
Supraclavicular Extraskeletal Myxoid Chondrosarcoma Presenting With a Sensorimotor Polyneuropathy Associated With Anti-Hu Antibodies
Reishi Mushroom
Reishi Mushroom
Unraveling the Mystery of a Supraclavicular Mass
Management of Relapsed Mantle Cell Lymphoma: Still a Treatment Challenge
Sunitinib Improves Progression-Free Survival in Patients With Advanced Pancreatic Islet Cell Tumors
Phase III Trial Initiated for BLP25 Liposome Vaccine in Breast Cancer Patients
US Oncology Launches Oncology-Specific EHR
Effective Local Therapy and Long-Term Survival in Breast Cancer
Local Therapy Matters
Deemphasize Dogma: Consider the Local Control–Overall Survival Link
Romiplostim for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura
The Road to Romiplostim Approval and Beyond
The REMS Publication Paradox
Recent Videos
Related Content
AI may transform oncology with Scout, an innovative assistant enhancing clinical insights and treatment strategies for TP53-mutant MCL and multiple myeloma.

AI-Powered Scout Platform Could Enhance Oncology Decision-Making With Data- and Expert-Driven Insights

Gina Mauro
November 1st 2025
Article

Stem Cell Transplant Approaches for Patients With Blood Cancers

Stem Cell Transplant Approaches for Patients With Blood Cancers

David T. Scadden, MD
March 13th 2019
Podcast

Dr. Scadden discusses which blood cancer patients are eligible for stem cell transplantation, as well as the latest advances in the field.

This trial combines pembrolizumab and trabedersen to enhance treatment for advanced NSCLC, targeting TGF-β2 for improved patient outcomes.

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC

Omar K. Abughanimeh, MBBS;Anthony E. Maida III, PhD, MA, MBA;Sanjive Qazi, PhD;Kate-Lynn Muir, DO;Bhavina Sharma MD;Lynette Smith, PhD;Apar Kishor Ganti, MD
October 30th 2025
Article

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Geoffrey Y. Ku, MD
March 13th 2019
Podcast

Dr. Ku discusses considerations in the treatment of esophageal cancer, current treatments, and the emerging role of immunotherapy.

Granulosa cell tumors exhibit late recurrence and rare hepatic metastasis, emphasizing the need for lifelong surveillance in affected patients.

Late Hepatic Recurrence From Granulosa Cell Tumor: A Case Report

Prosper Akankwasa, MBBS;Jackson Kakooza, MBBS;Aisha Abdullahi Ahmed, MBBS;Catherine R. Lewis, MD, PhD
October 28th 2025
Article

Granulosa cell tumors exhibit late recurrence and rare hepatic metastasis, emphasizing the need for lifelong surveillance in affected patients.

Explore a rare case of vulvar epithelioid sarcoma, highlighting the role of SMARCB1 loss and the challenges of radiotherapy in treatment.

Unraveling the Complexities of Proximal-Type Epithelioid Sarcoma of the Vulva

Fatimah M. Kaabi, MBBS;Chaker Zaidi, MD, PhD;Fatimah Abdullah Alessa, MBBS;Yasser Sorour, MD, PhD
October 27th 2025
Article